Celldex Therapeutics buy Wolfe Research
Start price
23.03.26
/
50%
€28.40
Target price
23.03.27
€38.10
Performance (%)
-12.50%
Price
03.06.26
€24.50
Summary
This prediction is currently active. The price of Celldex Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.50%. This prediction currently runs until 23.03.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -6.274% | -6.274% |
| iShares Core DAX® | -1.756% | 1.667% |
| iShares Nasdaq 100 | 2.324% | 12.779% |
| iShares Nikkei 225® | 5.022% | 13.300% |
| iShares S&P 500 | 0.802% | 6.198% |
Comments by Wolfe_Research for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $44.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wolfe_Research for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.60
25.09.24
25.09.24
€45.76
25.09.25
25.09.25
-27.70%
26.09.25
26.09.25
Celldex Therapeutics
Start price
Target price
Perf. (%)
€32.00
11.06.24
11.06.24
€47.50
11.06.25
11.06.25
-45.31%
12.06.25
12.06.25